Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "hyperplasia" wg kryterium: Wszystkie pola


Tytuł:
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency – management and differentiation in adults
Autorzy:
Nowak, Anna
Powiązania:
https://bibliotekanauki.pl/articles/1066263.pdf
Data publikacji:
2019
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
21-hydroxylase
androgens
congenital adrenal hyperplasia
glucocorticosteroids
Opis:
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is one of the most common autosomal recessive hereditary diseases. The lack of cortisol synthesis leads to excessive stimulation of the adrenal glands by adrenocorticotropic hormone (ACTH). Moreover the impairment of cortisol synthesis results in adrenal hyperplasia and excessive androgen synthesis. Congenital adrenal hyperplasia is characterised by a considerable correlation between the genotype and the phenotype with the type of CYP21A2 gene mutation affecting the severity of 21-hydroxylase deficiency. The clinical manifestations of congenital adrenal hyperplasia in adults result from adrenocortical insufficiency, hyperandrogenism, and the adverse effects of glucocorticosteroids, which are used for the treatment of the syndrome. Non-classic congenital adrenal hyperplasia may sometimes have no clinical manifestation. Patients with classic congenital adrenal hyperplasia experience a wide variety of symptoms, including obesity, hypertension, hyperinsulinaemia, insulin resistance, and hyperleptinaemia. These abnormalities, the same as glucocorticosteroid treatment, promote the development of other diseases, such as metabolic syndrome, diabetes mellulitis, cardiovascular diseases and psychosocial problems. Moreover glucocorticosteroids treatment increases risk of osteoporosis and dermatological disorders. The maladies are more often seen in patients suffering from congenital adrenal hyperplasia syndrome than in the general population. Patients suffering from congenital adrenal hyperplasia require systematic evaluation of biochemical parameters (17-hydroxyprogesterone and androstendion) the same as clinical parameters (body mass index, waist circumference, glucose, lipids, blood pressure). Medical care for patients suffering from congenital adrenal hyperplasia should be provided by reference centres. Patients require cooperation between an endocrinologist, diabetologist, gynaecologist, andrologist, urologist, sexuologist and psychologist.
Źródło:
World Scientific News; 2019, 130; 71-81
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
A practical algorithm management of patients with benign prostatic hyperplasia
Autorzy:
Dutkiewicz, S.
Powiązania:
https://bibliotekanauki.pl/articles/3168.pdf
Data publikacji:
2008
Wydawca:
Instytut Medycyny Wsi
Tematy:
algorithm management
human disease
patient
benign prostate hyperplasia
hyperplasia
man
urinary outflow obstruction
enlargement
prostate
alpha1-adrenoreceptor blocker
5-alpha-reductase inhibitor
combination therapy
surgical treatment
Źródło:
Journal of Pre-Clinical and Clinical Research; 2008, 02, 2
1898-2395
Pojawia się w:
Journal of Pre-Clinical and Clinical Research
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods
Autorzy:
Podgórski, Rafał
Aebisher, David
Stompor, Monika
Podgórska, Dominika
Mazur, Artur
Powiązania:
https://bibliotekanauki.pl/articles/1038519.pdf
Data publikacji:
2018
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
Congenital Adrenal Hyperplasia
CAH
steroidogenesis
21-hydroxylase deficiency
Opis:
The aim of this paper is a straightforward presentation of the steroidogenesis process and the most common type of congenital adrenal hyperplasia (CAH) - 21-hydroxylase deficiency - as well as the analytical diagnostic methods that are used to recognize this disease. CAH is a family of common autosomal recessive disorders characterized by impaired adrenal cortisol biosynthesis with associated androgen excess due to a deficiency of one or more enzymes in the steroidogenesis process within the adrenal cortex. The most common and prototypical example of the CAH disorders group (90-95%) is caused by 21-hydroxylase deficiency. Less frequent types of CAH are 11β-hydroxylase deficiency (up to 8% of cases), 17α-hydroxylase deficiency, 3β-hydroxysteroid dehydrogenase deficiency, P450 oxidoreductase deficiency and StAR deficiencies. In the 21-hydroxylase and 11β-hydroxylase deficiency, only adrenal steroidogenesis is affected, whereas a defect in 3β-hydroxysteroid dehydrogenase or 17α-hydroxylase also involves gonadal steroid biosynthesis. Many countries have introduced newborn screening programs based on immunoassays measuring 17-hydroxyprogesterone from blood spots used for other neonatal screening tests which enable faster diagnosis and treatment of CAH. Currently, chromatographic techniques coupled with mass spectrometry are gaining popularity due to an increase in the reliability of the test results.
Źródło:
Acta Biochimica Polonica; 2018, 65, 1; 25-33
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia
Autorzy:
Socha, P.
Zduńczyk, S.
Tobolski, D.
Janowski, T.
Powiązania:
https://bibliotekanauki.pl/articles/2087646.pdf
Data publikacji:
2018
Wydawca:
Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:
dogs
benign prostatic hyperplasia
osaterone acetate
prostate volume
Źródło:
Polish Journal of Veterinary Sciences; 2018, 21, 4; 797-802
1505-1773
Pojawia się w:
Polish Journal of Veterinary Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Zastosowanie palmy sabałowej w terapii łagodnego przerostu prostaty
The use of saw palmetto in the treatment of benign prostatic hyperplasia
Autorzy:
Zielińska, Agnieszka
Powiązania:
https://bibliotekanauki.pl/articles/11340522.pdf
Data publikacji:
2023-09-01
Wydawca:
Wydawnictwo Naukowe Medyk sp. z o.o.
Tematy:
prostata
łagodny rozrost gruczołu krokowego
palma sabałowa
kwasy tłuszczowe
prostate
benign prostatic hyperplasia
saw palmetto
fatty acids
Opis:
Palma sabałowa (Serenoa repens, bocznia piłkowana, Saw palmetto) pochodzi z południowo-wschodniej Ameryki Północnej, głównie z Florydy. W fitoterapii stosowany jest ekstrakt z jagód zawierający 85–90% kwasów tłuszczowych (m.in. kaprylowy, palmitynowy, oleinowy) oraz steroli, takich jak beta-sitosterol. Ekstrakt powszechnie spożywany jest jako suplement we wspomaganiu leczenia objawów ze strony dolnych dróg moczowych u mężczyzn oraz w łagodnym przeroście prostaty. Pomimo dużej liczby publikacji, niejasna jest jego potencjalna rola w leczeniu tych schorzeń. Jednak wielu specjalistów zaleca stosowanie preparatów zawierających wysokiej jakości lipidowo-sterolowy ekstrakt z palmy jako terapię wspomagającą w przypadku łagodnych do umiarkowanych objawów.
Saw palmetto (Serenoa repens) is native to the southeast regions of North America, especially abundant in Florida. The extract from its berries is used in phytotherapy, containing 85–90% of fatty acids (including caprylic, palmitic, oleic acids) and sterols such as beta-sitosterol. Lipidosterolic extract is commonly consumed as a supplement to support the treatment of lower urinary tract symptoms in men and benign prostatic hyperplasia. Despite the large number of publications, uncertainty remains about its potential role in the treatment of these conditions. However, many specialists recommend the use of preparations containing high-quality lipidosterolic palm extract as an adjunctive therapy for mild to moderate symptoms.
Źródło:
Lek w Polsce; 2023, 387, 8; 29-33
2353-8597
Pojawia się w:
Lek w Polsce
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The profile of ErbB/Her family genes copy number assessed by real-time PCR in parathyroid adenoma and hyperplasia associated with sporadic primary hyperparathyroidism
Autorzy:
Bednarz, Natalia
Błaut, Krzysztof
Sworczak, Krzysztof
Osęka, Tomasz
Bielawski, Krzysztof
Powiązania:
https://bibliotekanauki.pl/articles/1040637.pdf
Data publikacji:
2009
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
parathyroid hyperplasia
hyperparathyroidism
parathyroid adenoma
ErbB/Her
quantitative real-time PCR
Opis:
Hyperparathyroidism (pHPT) is a relatively frequent endocrinopathy, however, the molecular mechanisms of its etiology remain poorly understood. This disorder is mainly associated with benign tumours (adenoma) and hyperplasia of the parathyroid, hence, the focus is directed also to genes that are likely to be involved in carcinogenesis. Among such genes are ErbB/Her family genes already used in diagnosis of other tumours (e.g., breast carcinoma) and reported also to play a role in development of endocrine lesions. So far, ErbB-1/Her-1/EGFR expression has been detected in pHPT-associated adenomas and hyperplasia as opposed to no expression in normal parathyroid tissue. Moreover, losses or gains of the fragments of chromosomes where ErbB/Her genes are located have been reported. In this study, the gene dosage of ErbB/Her family genes were determined for the first time in parathyroid adenomas, hyperplasia and morphologically unchanged tissue in order to establish their putative role in the development of the disease. Genomic DNA was isolated from 33 patients with sporadic hyperparathyroidism and the gene copy numbers were assessed using real-time PCR. The ErbB/Her genes' profile was unaltered in most of the examined samples. Two low-level amplifications of ErbB-1/Her-1/EGFR gene, two deletions of ErbB-2/Her-2, and six deletions of ErbB-4/Her-4 were found. The ErbB-3/Her-3 gene remained unaffected. No correlation with clinical parameters was found for any gene. Both the low number of alterations and a lack of their associations with clinical parameters exclude the prognostic value of the ErbB/Her genes family in parathyroid tumourigenesis. Nevertheless, the ErbB-4/Her-4 deletions seem to be interesting for further investigations, especially in the context of PTH secretion.
Źródło:
Acta Biochimica Polonica; 2009, 56, 1; 83-88
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Synchronous occurrence of multiple focal nodular hyperplasia and huge hepatic Perivascular epithelioid cells tumor (PEComa) in young woman after oral contraceptive use – is there a common pathogenesis?
Autorzy:
Durczyński, Adam
Hogendorf, Piotr
Szymański, Dariusz
Sporny, Stanisław
Strzelczyk, Janusz
Powiązania:
https://bibliotekanauki.pl/articles/1396820.pdf
Data publikacji:
2012-10-01
Wydawca:
Index Copernicus International
Tematy:
liver
perivascular epithelioid cells tumor
focal nodular hyperplasia
oral contraceptive
Opis:
The association of focal nodular hyperplasia (FNH) and various neoplasms was described, but coincidence of multiple FNH and hepatic perivascular epithelioid cells tumor (PEComa) has not been reported. The clinical debate of oral contraceptive (OC) influence on FNH growth is ongoing, but no evidence exists about association of hepatic PEComa with OC use. Herein, we report a case of two FNH lesions and huge (150x100x80 mm) left hepatic lobe PEComa that occurred simultaneously in 18-year-old female with previous two year history of OC use, who underwent left hemihepatectomy and right hepatic FNH enucleation. Up to date, the patient has been followed-up for 65 months and remained disease-free. FNH and PEComa have a common vascular cytogenetic denominator. Our case raising a question of a causal relationship of FNH and PEComa with OC use that might be attributed to vascular changes. Future researches of larger sample sizes should further address this issue.
Źródło:
Polish Journal of Surgery; 2012, 84, 9; 457-460
0032-373X
2299-2847
Pojawia się w:
Polish Journal of Surgery
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Thermobalancing therapy as a self-management tool
Autorzy:
Allen, Simon
Powiązania:
https://bibliotekanauki.pl/articles/1076998.pdf
Data publikacji:
2019
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
benign prostatic hyperplasia
chronic prostatitis
disease management
kidney stone
thermobalancing therapy
Opis:
People live with one or more chronic diseases, medical and surgical treatments of which may affect their quality of life negatively. Thermobalancing therapy (TT) and Dr Allen’s therapeutic Devices (DATD) for the first time uses own body energy to treat chronic internal diseases. This invention received a US patent. Here we observe condition of people with benign prostatic hyperplasia (BPH), kidney stone disease and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) before and after use of TT and DATD. 10 years of empirical evidence has been studied in people with kidney disease, CP/CPPS and BPH. 2 clinical controlled trials on TT with DATD were conducted. The dynamics of clinical characteristics and parameters, such as pain, urinary symptoms and ultrasound prostate volume (PV), were compared with the no-treatment control groups. 124 men with BPH and 45 men with CP/CPPS used DATD for 6-month period, as mono-therapy, in clinical trials. The outcomes confirmed that TT with DATD reduced pain and PV in men with CP/CPPS and PV and urinary symptoms in men with BPH, while there were no positive changes in the control groups. 4 people with kidney stones, random from the 10-year follow-up, confirmed that after using DATD kidney stones were dissolved without side effects and complications. DATD is a class-1 medical device, which do not need an involvement of notified body, and it is easy use this device. Therefore, people with kidney stones, CP/CPPS and BPH should use DATD, as a tool for self-management in the first place.
Źródło:
World News of Natural Sciences; 2019, 23; 84-93
2543-5426
Pojawia się w:
World News of Natural Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Rzekomołożyskowy rozrost endometrium u suk
Pseudo-placentational endometrial hyperplasia in bitches
Autorzy:
Max, A.
Powiązania:
https://bibliotekanauki.pl/articles/860199.pdf
Data publikacji:
2017
Wydawca:
Krajowa Izba Lekarsko-Weterynaryjna
Tematy:
psy
suki
zaburzenia rozrodu
rzekomolozyskowy rozrost endometrium
przyczyny
patogeneza
Źródło:
Życie Weterynaryjne; 2017, 92, 10
0137-6810
Pojawia się w:
Życie Weterynaryjne
Dostawca treści:
Biblioteka Nauki
Artykuł

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies